技術(shù)外包服務(wù):

★磷酸化原癌基因c-Raf抗體品牌 分子生物學(xué)：質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué)：基因合成、引物合成、基因測(cè)序、載體構(gòu)建等

★蛋白工程：原核、哺乳動(dòng)物蛋白表達(dá)系統(tǒng)等

★病毒包裝：腺病毒、慢病毒等

★抗體工程：磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等

★細(xì)胞工程：細(xì)胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細(xì)胞培養(yǎng)、細(xì)胞膜制備、穩(wěn)定細(xì)胞株構(gòu)建、細(xì)胞RNAi技術(shù)等等。

實(shí)驗(yàn)流程：

磷酸化原癌基因c-Raf抗體品牌 英文名稱  Anti-phospho-c-Raf(Ser338)

中文名稱  磷酸化原癌基因c-Raf抗體品牌 

別    名 RAF1(phospho S338); Raf1(Phospho-Ser338); RAF1; murine leukemia viral (v-raf-1) oncogene homolog 1 (3611-MSV); v-raf-1 murine leukemia viral oncogene homolog 1; cRaf; C-RAF; proto-oncogene c-RAF; 6430402F14Rik; AA990557; BB129353; c-Raf; Craf1; D830050J10Rik; MGC102375; Raf-1; Raf 1; v-Raf; c Raf; Craf 1 transforming gene; Craf1 transforming gene; EC 2.7.11.1; Murine sarcoma 3611 oncogene 1; RAF; Raf proto oncogene serine/threonine protein kinase; vraf1 murine leukemia viral oncogene homolog 1; c-Raf.

產(chǎn)品屬性：

濃    度  1mg/1ml

規(guī) 格  0.1ml/100μg

抗體來(lái)源  Rabbit

克隆類型   polyclonal

交叉反應(yīng)   Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Rabbit, Sheep

產(chǎn)品類型   一抗 磷酸化抗體  

研究領(lǐng)域     免疫學(xué) 信號(hào)轉(zhuǎn)導(dǎo) 細(xì)胞凋亡 轉(zhuǎn)錄調(diào)節(jié)因子 激酶和磷酸酶

蛋白分子量  predicted molecular weight: 73kDa 

性    狀   Lyophilized or Liquid

免 疫 原  KLH conjugated synthesised phosphopeptide derived from human c-Raf around the phosphorylation site of Ser338

亞    型  IgG

純化方法   affinity purified by Protein A

儲(chǔ) 存 液   0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide

磷酸化原癌基因c-Raf抗體品牌 產(chǎn)品應(yīng)用   WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復(fù)） 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存條件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

產(chǎn)品介紹 The Raf family of serine/threonine specific kinases is comprised of three members (aRaf, bRaf, and cRaf) that play a critical role in regulating cell growth and differentiation, and couple growth factor receptor stimulation to nuclear transcription factors via the Ras/mitogen activated protein kinase (MAPK) pathway. cRaf kinase (also known as Raf1) is a small GTPase like kinase of 73 kDa, and is a signal transducer of multiple extracellular stimuli that is regulated by several pathways, and that once activated, phosphorylates MEK which in turn phosphorylates ERK. Raf1 is involved in the transduction of mitogenic signals from the cell membrane to the nucleus. It is part of the Ras dependent signaling pathway from receptors to the nucleus.

Function : Serine/threonine-protein kinase that acts as a regulatory link between the membrane-associated Ras GTPases and the MAPK/ERK cascade, and this critical regulatory link functions as a switch determining cell fate decisions including proliferation, differentiation, apoptosis, survival and oncogenic transformation. RAF1 activation initiates a mitogen-activated protein kinase (MAPK) cascade that comprises a sequential phosphorylation of the dual-specific MAPK kinases (MAP2K1/MEK1 and MAP2K2/MEK2) and the extracellular signal-regulated kinases (MAPK3/ERK1 and MAPK1/ERK2). The phosphorylated form of RAF1 (on residues Ser-338 and Ser-339, by PAK1) phosphorylates BAD/Bcl2-antagonist of cell death at 'Ser-75'. Phosphorylates adenylyl cyclases: ADCY2, ADCY5 and ADCY6, resulting in their activation. Phosphorylates PPP1R12A resulting in inhibition of the phosphatase activity. Phosphorylates TNNT2/cardiac muscle troponin T. Can promote NF-kB activation and inhibit signal transducers involved in motility (ROCK2), apoptosis (MAP3K5/ASK1 and STK3/MST2), proliferation and angiogenesis (RB1). Can protect cells from apoptosis also by translocating to the mitochondria where it binds BCL2 and displaces BAD/Bcl2-antagonist of cell death. Regulates Rho signaling and migration, and is required for normal wound healing. Plays a role in the oncogenic transformation of epithelial cells via repression of the TJ protein, occludin (OCLN) by inducing the up-regulation of a transcriptional repressor SNAI2/SLUG, which induces down-regulation of OCLN. Restricts caspase activation in response to selected stimuli, notably Fas stimulation, pathogen-mediated macrophage apoptosis, and erythroid differentiation. [CATALYTIC ACTIVITY] ATP + a protein = ADP + a phosphoprotein.

Subunit : Monomer. Homodimer. Heterodimerizes with BRAF and this heterodimer possesses a highly increased kinase activity compared to the respective homodimers or monomers. Heterodimerization is mitogen-regulated and enhanced by 14-3-3 proteins. MAPK1/ERK2 activation can induce a negative feedback that promotes the dissociation of the heterodimer. Forms a multiprotein complex with Ras (M-Ras/MRAS), SHOC2 and protein phosphatase 1 (PPP1CA, PPP1CB and PPP1CC). Interacts with Ras proteins; the interaction is antagonized by RIN1. Weakly interacts with RIT1. Interacts (via N-terminus) with RGS14 (via RBD domains); the interaction mediates the formation of a ternary complex with BRAF, a ternary complex inhibited by GNAI1 (By similarity). Interacts with STK3/MST2; the interaction inhibits its pro-apoptotic activity. Interacts (when phosphorylated at Ser-259) with YWHAZ (unphosphorylated at 'Thr-232'). Interacts with MAP2K1/MEK1 and MAP2K2/MEK2 (By similarity). Interacts with MAP3K5/ASF1 (via N-terminus) and this interaction inhibits the proapoptotic function of MAP3K5/ASK1. Interacts with PAK1 (via kinase domain). The phosphorylated form interacts with PIN1. The Ser-338 and Ser-339 phosphorylated form (by PAK1) interacts with BCL2. Interacts with PEBP1/RKIP and this interaction is enhanced if RAF1 is phosphorylated on residues Ser-338, Ser-339, Tyr-340 and Tyr-341. Interacts with ADCY2, ADCY5, ADCY6, DGKH, RCAN1/DSCR1, ROCK2, PPP1R12A, PKB/AKT1, PPP2CA, PPP2R1B, SPRY2, SPRY4, CNKSR1/CNK1, KSR2 and PHB/prohibitin.

Subcellular Location : Cytoplasm. Cell membrane. Mitochondrion. Nucleus. Note=Colocalizes with RGS14 and BRAF in both the cytoplasm and membranes. Phosphorylation at Ser-259 impairs its membrane accumulation. Recruited to the cell membrane by the active Ras protein. Phosphorylation at Ser-338 and Ser-339 by PAK1 is required for its mitochondrial localization. Retinoic acid-induced Ser-621 phosphorylated form of RAF1 is predominantly localized at the nucleus.

Tissue Specificity : In skeletal muscle, isoform 1 is more abundant than isoform 2. [PTM] Phosphorylated upon DNA damage, probably by ATM or ATR. Phosphorylation at Thr-269, Ser-338, Tyr-341, Thr-491 and Ser-494 results in its activation. Phosphorylation at Ser-29, Ser-43, Ser-289, Ser-296, Ser-301 and Ser-642 by MAPK1/ERK2 results in its inactivation. Phosphorylation at Ser-259 induces the interaction with YWHAZ and inactivates kinase activity. Dephosphorylation of Ser-259 by the complex containing protein phosphatase 1, SHOC2 and M-Ras/MRAS relieves inactivation, leading to stimulate RAF1 activity. Phosphorylation at Ser-338 by PAK1 and PAK7/PAK5 and Ser-339 by PAK1 is required for its mitochondrial localization.

DISEASE : Defects in RAF1 are the cause of Noonan syndrome type 5 (NS5) [MIM:611553]. Noonan syndrome (NS) is a disorder characterized by dysmorphic facial features, short stature, hypertelorism, cardiac anomalies, deafness, motor delay, and a bleeding diathesis. It is a genetically heterogeneous and relatively common syndrome, with an estimated incidence of 1 in 1000-2500 live births.

Defects in RAF1 are the cause of LEOPARD syndrome type 2 (LEOPARD2) [MIM:611554]. LEOPARD syndrome is an autosomal dominant disorder allelic with Noonan syndrome. The acronym LEOPARD stands for lentigines, electrocardiographic conduction abnormalities, ocular hypertelorism, pulmonic stenosis, abnormalities of genitalia, retardation of growth, and deafness.

Similarity : Belongs to the protein kinase superfamily. TKL Ser/Thr protein kinase family. RAF subfamily.

Contains 1 phorbol-ester/DAG-type zinc finger.

Contains 1 protein kinase domain.

Contains 1 RBD (Ras-binding) domain.

Database links : UniProtKB/Swiss-Prot: P04049.1

全、新、優(yōu)、品、好四大特點(diǎn)：

磷酸化原癌基因c-Raf抗體品牌 全：公司提供上萬(wàn)種產(chǎn)品，涵蓋了生物試劑，elisa試劑盒，標(biāo)準(zhǔn)品，培養(yǎng)基，原裝耗材，抗體、培養(yǎng)基、ATCC細(xì)胞等，基本上各種科研所需產(chǎn)品在我司都能找到。

新：產(chǎn)品更新速度較快，基本上每周都有新產(chǎn)品出現(xiàn)。

優(yōu)：產(chǎn)品質(zhì)量好，投訴比較少。

好：我公司具有優(yōu)質(zhì)的技術(shù)團(tuán)隊(duì)，產(chǎn)品一旦售出，實(shí)驗(yàn)過(guò)程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時(shí)沒(méi)有任何的后顧之憂。

正在熱銷的相關(guān)產(chǎn)品：

LN (laminin) 層粘連蛋白(多肽抗原)Multi-class antibodies規(guī)格： 0.5mg

Anti-ALK/CD246 間變型激酶抗體Multi-class antibodies規(guī)格： 0.2ml

Rhesus antibody Rh phospho-c-Abl(Tyr251) 磷酸化非受體酪氨酸激酶c-Abl抗體 規(guī)格 0.1ml

低背景抗體稀釋液 10ml/100ml pH 7.6

VWCE 英文名稱： VWCE抗體 0.2ml

phospho-DAXX (Ser495) 英文名稱： 磷酸化Fas相關(guān)死亡結(jié)構(gòu)域蛋白抗體 0.1ml

Anti-ALK/CD246 間變型激酶抗體Multi-class antibodies規(guī)格： 0.2ml

Anti-Phospho-delta Opioid Receptor (Ser363) /FITC 熒光素標(biāo)記磷酸化D型受體抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Rabbit Anti-mouse IgG/HRP 辣根過(guò)氧化物酶標(biāo)記兔抗小鼠IgGMulti-class antibodies規(guī)格： 0.1ml

c-erbB-2抗體 Anti-C-erbB-2 0.1ml

Rabbit Anti-horse IgM/Cy3 Cy3標(biāo)記的兔抗馬IgM 0.1ml

FABPB 英文名稱： 腦型脂肪酸結(jié)合蛋白抗體 0.2ml

Rhesus antibody Rh PKMYT1 髓鞘轉(zhuǎn)錄因子1激酶抗體 規(guī)格 0.1ml

Rabbit Anti-mouse IgG/HRP 辣根過(guò)氧化物酶標(biāo)記兔抗小鼠IgGMulti-class antibodies規(guī)格： 0.1ml

SEPT6 英文名稱： 細(xì)胞分化蛋白SEPT6抗體 0.2ml

EML3 英文名稱： 微管相關(guān)蛋白樣蛋白3抗體 0.2ml

組織蛋白酶K抗體 Anti-cath-K/CK 0.1ml

Anti-UG/FITC 熒光素標(biāo)記子宮珠蛋白抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Rhesus antibody Rh Phospho-Histone H3 (Thr3) 磷酸化組蛋白H3抗體 規(guī)格 0.1ml

CCR-7(CC chemokine receptor 7) CC趨化因子受體7(多肽)Multi-class antibodies規(guī)格： 0.5mg

rCSC, 大鼠心肌細(xì)胞

4179 長(zhǎng)尾綠猴胚胎細(xì)胞

IL1RL1 Others Human 人 IL1RL1 / ST2 ( isoform A ) 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)

CL-0271D283 Med(人腦髓母細(xì)胞瘤細(xì)胞)5×106cells/瓶×2

人成纖維細(xì)胞cDNAHCF cDNA

人APP-PS1雙基因轉(zhuǎn)染細(xì)胞株(HEK293);APP-PS1 人支持細(xì)胞完全培養(yǎng)基 100mL

CL-0151MDA-MB-435S(人導(dǎo)管癌細(xì)胞)5×106cells/瓶×2

CD3E Others Cynomolgus 食蟹猴 CD3e / CD3 epsilon 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)

小鼠肝動(dòng)脈內(nèi)皮細(xì)胞完全培養(yǎng)基 100mL

HCAEC人內(nèi)皮細(xì)胞 HCAEC in human coronary artery endothelial cells ECM(Sicencell Cat#1001)

IL11 Protein Human 重組人 IL11 / Ierleukin 11 / IL-11 蛋白

RKO-E6(人轉(zhuǎn)基因細(xì)胞) 5×106cells/瓶×2 Jecket(細(xì)胞)

磷酸化原癌基因c-Raf抗體品牌 rCSC, 大鼠心肌細(xì)胞

4179 長(zhǎng)尾綠猴胚胎細(xì)胞

IL1RL1 Others Human 人 IL1RL1 / ST2 ( isoform A ) 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)

CL-0271D283 Med(人腦髓母細(xì)胞瘤細(xì)胞)5×106cells/瓶×2

人成纖維細(xì)胞cDNAHCF cDNA

人APP-PS1雙基因轉(zhuǎn)染細(xì)胞株(HEK293);APP-PS1 人支持細(xì)胞完全培養(yǎng)基 100mL